Financhill
Back

Perspective Therapeutics 10K Form

Buy
89

CATX
Perspective Therapeutics

Last Price:
0.94
Seasonality Move:
6.3%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive CATX News And Ratings

See the #1 stock for the next 7 days that we like better than CATX

CATX Financial Statistics

Sales & Book Value

Annual Sales: $3.55M
Cash Flow: $-10.34M
Price / Cash Flow: 0
Annual Sales: $0.35
Price / Book: 2.7

Profitability

EPS (TTM): -0.11160
Net Income (TTM): $-25.9M
Gross Margin: $817K
Return on Equity: -29.14%
Return on Assets: -26.69%

Perspective Therapeutics Earnings Forecast

Key Perspective Therapeutics Financial Ratios

  • The Gross Profit Margin over the past 29 years for CATX is 23.00%.
  • The Selling, General & Administrative Expenses for CATX have been equal to 200.08% of Gross Profit Margin.
  • The Research & Development expenses have been 36.63% of Revenue.
  • The Interest Expense is -0.02% of Operating Income.
  • The Net Earning history of CATX is -206.50% of Total Revenues.
  • Per Share Earnings over the last 29 years have been positive in 16 years.

Perspective Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYAM
Industry: Medical Devices
Sector: Healthcare
Current Symbol: CATX
Website: perspectivetherapeutics.com

Debt

Debt-to-Equity Ratio: 0.02
Current Ratio: 2.67
Quick Ratio: 2.43

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

CATX Technical Analysis vs Fundamental Analysis

Buy
89
Perspective Therapeutics (CATX) is a Buy

Is Perspective Therapeutics a Buy or a Sell?